Market Cap N/A
Revenue (ttm) 152.58M
Net Income (ttm) -41.57M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -27.24%
Debt to Equity Ratio N/A
Volume 461,700
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list o...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: (650) 460-2551
Address:
1035 O’Brien Drive, Menlo Park, United States
Annie_Preferred
Annie_Preferred Dec. 29 at 8:39 PM
$BLLN If one looks at the total stock market and insider buying, only the biotech market has insiders buying. Biotech has the most opportunity! This will eventually come back!
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 3:14 PM
Actionable Trade Alert for $BLLN: Market Context: $BLLN is currently trading at $86.34, with a 60-day high of $138.7 and a low of $81.51. The RSI at 37.9 indicates that the stock is nearing oversold territory, suggesting potential upward momentum. The absence of MA50 and MA200 data limits long-term trend analysis, but the MA30 at 103.25 indicates a significant resistance level. Directional Bias: With the RSI below 40, there's a bearish sentiment, but the proximity to the 60-day low and oversold RSI suggests a potential reversal. Trade Plan: - Suggested Entry: $86.50 - Stop Loss: $81.00 (approximately 6% risk) - Take Profit Targets: 1. $96.00 (11% ROI) 2. $106.00 (23% ROI) 3. $101.00 (17% ROI) This plan allows for a calculated risk with a potential for significant returns, capitalizing on the current market conditions and technical indicators. https://privateprofiteers.com
0 · Reply
v92
v92 Dec. 24 at 2:52 PM
$BLLN Yikes. First false negatives and now NTRA launches a better test. These guys got lucky getting IPO launched.
0 · Reply
Steve1B
Steve1B Dec. 23 at 4:48 PM
$BLLN I'm in for a minute with 500 shares unless I'm near the bottom then I'll stay in it to win it
0 · Reply
LongVester
LongVester Dec. 19 at 8:28 PM
$BLLN Similar to $GRAL but even better. 👀
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 5:10 PM
Actionable Trade Alert for $BLLN Market Context: $BLLN is currently trading at $95.5, significantly below its 60-day high of $138.7, indicating a potential for recovery. The RSI at 28.88 suggests that the stock is oversold, which may lead to a bullish reversal in the near term. Directional Bias: Given the RSI reading and the proximity to the 60-day low of $88.0, there is a strong likelihood of upward momentum. The absence of MA50 and MA200 limits resistance levels, allowing for a more favorable risk-reward scenario. Trade Plan: - Suggested Entry: $95.5 - Stop Loss: $88.0 (risking $7.5) - Take Profit Targets: 1. TP1: $105.5 (17% ROI) 2. TP2: $115.5 (21% ROI) 3. TP3: $112.0 (17% ROI) With the ATR at 10.63, the stock has the potential to move significantly, supporting the targets. Monitor the price action closely and adjust the stop loss as necessary to protect profits. https://privateprofiteers.com
0 · Reply
Bazzzigar
Bazzzigar Dec. 17 at 1:03 PM
$BLLN join with HIMS
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 3:55 AM
Actionable Trade Alert for $BLLN: Market Context: $BLLN is currently trading at $91.96, significantly below its 60-day high of $138.7, indicating potential for a rebound. The RSI of 27.13 suggests that the stock is oversold, which can lead to a price correction. Directional Bias: Given the oversold RSI, a bullish reversal is likely. The absence of moving averages (MA30, MA50, MA200) limits resistance levels, allowing for potential upward movement. Trade Plan: - Suggested Entry: $92.00 - Stop Loss: $88.00 (below the 60D low) - Take Profit Targets: 1. TP1: $105.00 (13.5% ROI) 2. TP2: $115.00 (24.5% ROI) 3. TP3: $108.00 (17.5% ROI) With the ATR at 11.27, this trade plan accommodates volatility while targeting significant gains. Monitor price action closely for potential adjustments. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Goldilocks3
Goldilocks3 Dec. 16 at 3:23 PM
$BLLN for all the people saying fraud and thermos, my friend works there. The providers love their tests and use them all the time and tight run ship.
0 · Reply
LongVester
LongVester Dec. 15 at 7:06 PM
$BLLN This is going to be the next $GRAL but only bigger.
0 · Reply
Latest News on BLLN
BillionToOne, Inc. (BLLN) Q3 2025 Earnings Call Transcript

Dec 12, 2025, 5:12 PM EST - 18 days ago

BillionToOne, Inc. (BLLN) Q3 2025 Earnings Call Transcript


BillionToOne Reports Third Quarter 2025 Results

Dec 9, 2025, 4:05 PM EST - 21 days ago

BillionToOne Reports Third Quarter 2025 Results


BillionToOne: A Deserved Opening Day Boom

Nov 7, 2025, 3:17 AM EST - 7 weeks ago

BillionToOne: A Deserved Opening Day Boom


BillionToOne targets over $2 billion valuation in US IPO

Oct 17, 2025, 6:09 PM EDT - 2 months ago

BillionToOne targets over $2 billion valuation in US IPO


BillionToOne Launches IPO In Slowing IPO Market

Oct 13, 2025, 12:23 PM EDT - 2 months ago

BillionToOne Launches IPO In Slowing IPO Market


Molecular diagnostics firm BillionToOne files for US IPO

Oct 7, 2025, 6:17 PM EDT - 3 months ago

Molecular diagnostics firm BillionToOne files for US IPO


BillionToOne IPO Registration Document (S-1)

Oct 7, 2025, 5:30 PM EDT - 3 months ago

BillionToOne IPO Registration Document (S-1)


Annie_Preferred
Annie_Preferred Dec. 29 at 8:39 PM
$BLLN If one looks at the total stock market and insider buying, only the biotech market has insiders buying. Biotech has the most opportunity! This will eventually come back!
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 3:14 PM
Actionable Trade Alert for $BLLN: Market Context: $BLLN is currently trading at $86.34, with a 60-day high of $138.7 and a low of $81.51. The RSI at 37.9 indicates that the stock is nearing oversold territory, suggesting potential upward momentum. The absence of MA50 and MA200 data limits long-term trend analysis, but the MA30 at 103.25 indicates a significant resistance level. Directional Bias: With the RSI below 40, there's a bearish sentiment, but the proximity to the 60-day low and oversold RSI suggests a potential reversal. Trade Plan: - Suggested Entry: $86.50 - Stop Loss: $81.00 (approximately 6% risk) - Take Profit Targets: 1. $96.00 (11% ROI) 2. $106.00 (23% ROI) 3. $101.00 (17% ROI) This plan allows for a calculated risk with a potential for significant returns, capitalizing on the current market conditions and technical indicators. https://privateprofiteers.com
0 · Reply
v92
v92 Dec. 24 at 2:52 PM
$BLLN Yikes. First false negatives and now NTRA launches a better test. These guys got lucky getting IPO launched.
0 · Reply
Steve1B
Steve1B Dec. 23 at 4:48 PM
$BLLN I'm in for a minute with 500 shares unless I'm near the bottom then I'll stay in it to win it
0 · Reply
LongVester
LongVester Dec. 19 at 8:28 PM
$BLLN Similar to $GRAL but even better. 👀
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 5:10 PM
Actionable Trade Alert for $BLLN Market Context: $BLLN is currently trading at $95.5, significantly below its 60-day high of $138.7, indicating a potential for recovery. The RSI at 28.88 suggests that the stock is oversold, which may lead to a bullish reversal in the near term. Directional Bias: Given the RSI reading and the proximity to the 60-day low of $88.0, there is a strong likelihood of upward momentum. The absence of MA50 and MA200 limits resistance levels, allowing for a more favorable risk-reward scenario. Trade Plan: - Suggested Entry: $95.5 - Stop Loss: $88.0 (risking $7.5) - Take Profit Targets: 1. TP1: $105.5 (17% ROI) 2. TP2: $115.5 (21% ROI) 3. TP3: $112.0 (17% ROI) With the ATR at 10.63, the stock has the potential to move significantly, supporting the targets. Monitor the price action closely and adjust the stop loss as necessary to protect profits. https://privateprofiteers.com
0 · Reply
Bazzzigar
Bazzzigar Dec. 17 at 1:03 PM
$BLLN join with HIMS
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 3:55 AM
Actionable Trade Alert for $BLLN: Market Context: $BLLN is currently trading at $91.96, significantly below its 60-day high of $138.7, indicating potential for a rebound. The RSI of 27.13 suggests that the stock is oversold, which can lead to a price correction. Directional Bias: Given the oversold RSI, a bullish reversal is likely. The absence of moving averages (MA30, MA50, MA200) limits resistance levels, allowing for potential upward movement. Trade Plan: - Suggested Entry: $92.00 - Stop Loss: $88.00 (below the 60D low) - Take Profit Targets: 1. TP1: $105.00 (13.5% ROI) 2. TP2: $115.00 (24.5% ROI) 3. TP3: $108.00 (17.5% ROI) With the ATR at 11.27, this trade plan accommodates volatility while targeting significant gains. Monitor price action closely for potential adjustments. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Goldilocks3
Goldilocks3 Dec. 16 at 3:23 PM
$BLLN for all the people saying fraud and thermos, my friend works there. The providers love their tests and use them all the time and tight run ship.
0 · Reply
LongVester
LongVester Dec. 15 at 7:06 PM
$BLLN This is going to be the next $GRAL but only bigger.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 7:28 AM
Actionable Trade Alert for $BLLN: Market Context: $BLLN is currently trading at $101.99, with a 60-day high of $138.7 and a low of $88.0, indicating a significant range. The RSI at 45.69 suggests that the stock is neither overbought nor oversold, allowing for potential upward movement. Directional Bias: Given the current price is closer to the 60-day low, there is a bullish bias, especially if it breaks above recent resistance levels. The absence of moving averages indicates a lack of clear trend direction, supporting a range-bound trading strategy. Trade Plan: - Suggested Entry: $102.50 (slightly above current close) - Stop Loss: $95.00 (approximately 7.5% risk) - Take Profit Targets: 1. $115.00 (12% gain) 2. $125.00 (22% gain) 3. $119.00 (17% gain) This plan offers a potential ROI of over 17% on the third target while maintaining a reasonable risk-reward ratio. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Annie_Preferred
Annie_Preferred Dec. 13 at 12:01 AM
$BLLN Not sure why everyone is so bearish ... this picked up four followers this week!
0 · Reply
Annie_Preferred
Annie_Preferred Dec. 12 at 10:53 PM
$BLLN They will do some partner deals with a big pharma firm and then get bought out!
0 · Reply
Annie_Preferred
Annie_Preferred Dec. 12 at 2:36 AM
$BLLN Keep the faith ... it doesn't look like Theranos ... but a lot of people are naturally going to be skeptical when you start talking about some miracle blood test!
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:22 AM
Actionable Trade Alert for $BLLN: Market Context: $BLLN is currently trading at $96.65, positioned between its 60-day high of $138.7 and low of $88.0. The RSI at 50.47 indicates a neutral market sentiment, suggesting potential for upward movement. Directional Bias: Given the current price near the midpoint of the 60-day range, there is potential for a bullish breakout. The absence of moving averages (MA30, MA50, MA200) suggests a lack of strong trend resistance, allowing for upward momentum. Trade Plan: - Suggested Entry: $97.00 (slightly above current close) - Stop Loss: $92.00 (4.2% below entry) - Take Profit Targets: - TP1: $110.00 (13.4% ROI) - TP2: $115.00 (18.5% ROI) - TP3: $113.00 (16.5% ROI) This plan provides a solid risk-reward ratio, aiming for at least 17% ROI on TP3. Monitor market conditions closely for any changes. https://privateprofiteers.com
0 · Reply
Shadow_Blade_642
Shadow_Blade_642 Dec. 11 at 7:43 PM
$BLLN Mainz Biomed is trading so thin that every time a half-decent bid steps up the price ticks two, three cents at a time, that’s the beauty of a true microcap playground 🎢📈
0 · Reply
Bazzzigar
Bazzzigar Dec. 11 at 5:25 PM
0 · Reply
JarvisFlow
JarvisFlow Dec. 10 at 4:03 PM
JP Morgan updates rating for BillionToOne ( $BLLN ) to Overweight, target set at 150 → 145.
0 · Reply
Neeter
Neeter Dec. 10 at 1:46 PM
$BLLN JP Morgan cuts target price to $145 from $150 * Biogen Inc : Wells Fargo raises target price to $190 from $155 .Once it settles, increasing holdings.
0 · Reply
JarvisFlow
JarvisFlow Dec. 10 at 10:25 AM
BTIG updates rating for BillionToOne ( $BLLN ) to Buy, target set at 160.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:25 AM
Actionable Trade Alert for $BLLN: Market Context: $BLLN is currently trading at $109.53, positioned between its 60-day high of $138.7 and low of $88.0. The RSI at 55.43 indicates a neutral to slightly bullish sentiment, suggesting potential for upward movement. Directional Bias: Given the current price is closer to the 60-day high and the RSI is not overbought, there is a bullish bias. The absence of moving averages (MA30, MA50, MA200) indicates a lack of clear trend direction, but the price action within the high-low range supports a potential rally. Trade Plan: - Suggested Entry: $110.00 - Stop Loss: $104.00 (approx. 5.5% below entry) - Take Profit Targets: - Target 1: $120.00 (9.1% gain) - Target 2: $125.00 (13.6% gain) - Target 3: $128.00 (16.9% gain) With these targets, a successful trade could yield over 17% ROI on Target 3. Monitor closely and adjust as needed. https://privateprofiteers.com
0 · Reply
Bazzzigar
Bazzzigar Dec. 10 at 12:46 AM
$BLLN join with HIMS
0 · Reply